Back to search

Article

Development of an MTB39A protein-based Mycobacterium tuberculosis nanoparticle vaccine candidate

2023-05-08

Abstract excerpt

Tuberculosis (TB), a human and animal disease caused by Mycobacterium tuberculosis ( M.tb ), has the highest global mortality rate after coronavirus disease 2019 (COVID-19) and poses a major public health threat to China and several countries worldwide. Since 1890, vaccine candidates for various forms of TB have been developed for different age groups, but these vaccine candidates have not provided good protection...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fe0b5683-643f-5b5e-a750-4a0f313740c4
DOI
10.21203/rs.3.rs-2857203/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development of an MTB39A protein-based Mycobacterium tuberculosis nanoparticle vaccine candidateDOI 10.21203/rs.3.rs-2857203/v1
Advances in protein subunit vaccines against tuberculosisSemantic proximity
Developing next-generation tuberculosis vaccines based on pathogen–host interactions: Towards a holistic perspectiveSemantic proximity
Intervening along the spectrum of tuberculosis: meeting report from the World TB Day nanosymposium in the Institute of Infectious Disease and Molecular Medicine at the University of Cape TownSemantic proximity
Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trialsSemantic proximity
Novel In Silico mRNA vaccine design exploiting proteins of M. tuberculosis that modulates host immune responses by inducing epigenetic modificationsSemantic proximity
Development of innovative multi-epitope mRNA vaccine against central nervous system tuberculosis using in silico approachesSemantic proximity
Vaccination with mycobacterial lipid loaded nanoparticle leads to lipid antigen persistence and memory differentiation of antigen-specific T cellsSemantic proximity
Differential Immune Responses and Protective Efficacy Induced by Components of a Tuberculosis Polyprotein Vaccine, Mtb72F, Delivered as Naked DNA or Recombinant ProteinSemantic proximity
Mycobacterial EsxG·EsxH (TB9.8·TB10.4) peptides as a subunit vaccine to booster BCG vaccination in an experimental model of pulmonary TuberculosisSemantic proximity
A vaccine for global eradication of TB - A novel conceptual framework and design of a potent peptide-based vaccine with universal coverage through advanced computational vaccinologySemantic proximity
Therapeutic vaccination with the Ag85B-Rv2660c-MPT70 fusion protein enhances Mycobacterium tuberculosis H37Ra clearance in post-exposure miceSemantic proximity
Immunoinformatics and structural aided approach to develop multi-epitope based subunit vaccine against Mycobacterium tuberculosisSemantic proximity
Select a neighboring publication to make it the new centre.